Stuart A. Arbuckle

EVP, COO at Vertex Pharmaceuticals

As Vertex’s COO, Mr. Arbuckle oversees Vertex’s global Commercial team, which is responsible for the company’s reimbursement and access, sales, marketing, patient support, market research, as well as Commercial Manufacturing and Supply Chain, and other activities that support the approved use of Vertex’s marketed medicines around the world. Mr. Arbuckle also oversees the Human Resources and Corporate Communications functions.

Mr. Arbuckle has more than 30 years of experience leading global sales and marketing efforts at biopharmaceutical companies, including at Amgen and GlaxoSmithKline plc. Mr. Arbuckle currently serves as a member of Rhythm Pharmaceuticals and ImmunoGen's board of directors, as a national board member of the Cancer Support Community, and on the Executive Committee and Health Section Governing Board for the Biotechnology Innovation Organization (BIO). He is also co-chair of the BIO Standing Committee on Access & Value.

Mr. Arbuckle earned a degree in pharmacology and physiology from the University of Leeds in the United Kingdom.

Timeline

  • EVP, COO

    August, 2021 - present

  • EVP, Chief Commercial Officer